§ Federal grant opportunity · HT942526OCRPIIRA
DoW, Ovarian Cancer, Investigator-Initiated Research Award
Christopher Meinberg Grantor is accepting applications for DoW, Ovarian Cancer, Investigator-Initiated Research Award. The deadline is October 1, 2026 and the published award range is Award amount not published.
Key facts
- Funder
- Christopher Meinberg Grantor
- Application deadline
- October 1, 2026
- Award range
- Award amount not published
- Eligibility
- Eligibility criteria are published in the funding opportunity announcement.
- Geography
- United States
- Focus areas
- Research
- Opportunity number
- HT942526OCRPIIRA
Program overview
Summary: The Ovarian Cancer Research Program (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Distinctive Features: Application must contain strong research plan with sound scientific rational and logical reasoning. Preliminary data are required. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. Partnering Principal Investigator (PI) Option: The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, will work synergistically on a single project. The results of this partnering project should significantly advance the research beyond what would be possible through individual efforts.
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from Christopher Meinberg Grantor.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before October 1, 2026, allowing time for registration and validation.
Related grant opportunities
- DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator Award
- Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed)
- DoW Ovarian Cancer, Clinical Trial Award
- DoW, Ovarian Cancer, Pilot Award
- Novel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.